Skip to content

Examining Brain Responses Linked to Emotion in Individuals Who Smoke Cigarettes

Examining Brain Responses Linked to Emotion in Individuals Who Smoke Cigarettes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04310735
Enrollment
62
Registered
2020-03-17
Start date
2019-10-04
Completion date
2023-11-28
Last updated
2025-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking, Tobacco

Brief summary

The study will use functional magnetic resonance imaging and facial coding methods to study individuals who smoke cigarettes. Smoking expectancy (the extent to which one perceives an opportunity to smoke a cigarette) will be manipulated using instructions, and the investigators will examine the effects of this manipulation on two primary endpoints under conditions designed to induce an urge to smoke: (1) brain responses measured using fMRI and (2) subjective affective responses measured using facial coding. Secondary endpoints include self-report measures of the desire to smoke and current affect.

Interventions

BEHAVIORALVerbal smoking expectancy manipulation

Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Penn State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants must be between the ages of 21 and 55. * Participants must be right handed. * Participants must be fluent English speakers. * Participants must report smoking at least 6 cigarettes per day continuously for at least the 12 preceding months. * Participants must have a baseline expired air carbon monoxide (CO) exceeding a cutoff based upon prior research in order to verify smoking status.

Exclusion criteria

* Individuals will be excluded if they report that they are actively trying to quit smoking. * Individuals will be excluded if they report that they have had significant cardiovascular disease (such as heart disease, heart attack, stroke, or angina) or respiratory disease (such as asthma, chronic bronchitis, or COPD) during the past year. * Individuals will be excluded if they report that they have used any of the following illicit substances more than 10 times in the previous 30 days: marijuana, cocaine, opiates such as heroin, methadone, benzodiazepines (such as Valium, Xanax), barbiturates, amphetamines, methamphetamines, PCP, LSD or any other hallucinogen. * Individuals will be excluded if they report that they are currently taking prescription medications that previously have been found to affect blood flow responses in the brain. * Individuals will be excluded if they have any known risk from exposure to high-field strength magnetic fields (e.g., pace makers), any irremovable metallic foreign objects in their body (e.g., braces), or a questionable history of metallic fragments that are likely to create artifact on the MRI scans. * Individuals will be excluded if they meet criteria for current dependence on a substance other than nicotine based upon a brief structured interview. * Individuals will be excluded if they report that they are not willing to refrain from using alcohol and recreational drugs for 24 hours and nicotine for 12 hours before the experimental lab visit. * Individuals will be excluded if they currently use nicotine products other than cigarettes (e.g., chewing tobacco, snuff, e-cigarettes, or smoking cessation products). * Individuals will be excluded if they are claustrophobic or are prone to becoming very uncomfortable in confined spaces. * Individuals will be excluded if they report that they exclusively or primarily smoke roll-your-own cigarettes.

Design outcomes

Primary

MeasureTime frameDescription
Brain Activation During Smoking-related and Neutral CuesApproximately Day 7 (Visit 2)Blood-oxygen-level dependent (BOLD) signal measured using functional magnetic resonance imaging (fMRI) was analyzed as participants were presented with smoking-related and neutral cues. Following preprocessing with fMRIPrep (version 20.2.7), the FMRI Expert Analysis Tool (FEAT) from FMRIB's Software Library (FSL; version 6.0.7.4) was used to characterize brain activation differences in response to smoking-related versus neutral cues. Contrast of parameter estimate (COPE) values were calculated for each participant, and these COPE values were then extracted for two a priori regions of interest (ROIs) to compare activation patterns between the groups. Larger COPE values indicate greater differences in brain activation between smoking-related and neutral cues,
Coded Facial Expressions Linked to Affect During Smoking-related and Neutral CuesApproximately Day 7 (Visit 2)Subjective affective responses were measured by using FaceReader software (version 9.1.7) to code the valence (positive or negative) of facial movements associated with emotional expression during the presentation of smoking-related and neutral cues. Possible values for valence range from -1 to 1, with higher values indicating greater positive affect,

Secondary

MeasureTime frameDescription
Nicotine DependenceDay 1 (Visit 1)Participants' level of nicotine dependence was assessed using the total score on the Fagerström Test for Nicotine Dependence to help characterize the sample. Possible scores on the Fagerström Test for Nicotine Dependence range from 0 to 10, with higher scores indicating greater nicotine dependence.
Brain Activation During Positive and Negative Emotion CuesApproximately Day 7 (Visit 2)Blood-oxygen-level dependent (BOLD) signal measured using functional magnetic resonance imaging (fMRI) was analyzed as participants were presented with cues designed to elicit positive and negative emotion. Following preprocessing with fMRIPrep (version 20.2.7), the FMRI Expert Analysis Tool (FEAT) from FMRIB's Software Library (FSL; version 6.0.7.4) was used to characterize brain activation in response to positive and negative emotion cues. Contrast of parameter estimate (COPE) values were calculated for each participant, and these COPE values were then extracted for two a priori regions of interest (ROIs) to compare activation patterns between the groups. Larger COPE values indicate greater differences in brain activation between positive and negative emotion cues.
Self-reported Urge to Smoke During Smoking-related and Neutral CuesApproximately Day 7 (Visit 2)Participants rated their urge to smoke during the presentation of smoking-related and neutral cues on a scale ranging from 1 (not at all) to 9 (extremely), with higher scores indicating a stronger desire to smoke. For each type of cue (smoking-related and neutral), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.
Self-reported Urge to Smoke During Positive and Negative Emotion CuesApproximately Day 7 (Visit 2)Participants rated their urge to smoke during the presentation of cues designed to elicit positive and negative emotions on a scale ranging from 1 (not at all) to 9 (extremely), with higher scores indicating a stronger desire to smoke. For each type of cue (positive and negative emotion), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.
Self-reported Affect During Positive and Negative Emotion CuesApproximately Day 7 (Visit 2)Participants rated their current affect during the presentation of cues designed to elicit positive and negative emotion on a scale ranging from 1 (very negative) to 9 (very positive), with higher scores indicating greater positive affect. For each type of cue (positive and negative emotion), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.
Coded Facial Expressions Linked to Affect During Positive and Negative Emotion CuesApproximately Day 7 (Visit 2)Subjective affective responses were measured by using FaceReader software (version 9.1.7) to code the valence (positive or negative) of facial movements associated with emotional expression during the presentation of cues designed to elicit positive and negative emotion. Possible values for valence range from -1 to 1, with higher values indicating greater positive affect,
Self-reported Affect During Smoking-related and Neutral CuesApproximately Day 7 (Visit 2)Participants rated their current affect during the presentation of smoking-related and neutral cues on a scale ranging from 1 (very negative) to 9 (very positive), with higher scores indicating greater positive affect. For each type of cue (smoking-related and neutral), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.

Countries

United States

Participant flow

Participants by arm

ArmCount
Experimental: Expect-Yes
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will perceive an opportunity to smoke during the experimental session. Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
14
Experimental: Expect-No
Participants assigned to this condition will undergo a verbal smoking expectancy manipulation such that they will not perceive an opportunity to smoke during the experimental session. Verbal smoking expectancy manipulation: Instructions regarding whether or not participants will have an opportunity to smoke during the experimental session.
13
Behavioral Testing
Participants asked to complete behavioral testing only during experimental session for initial piloting, to allow progress toward the aims of the project while research was initially shut down and then subsequently restricted due to the COVID-19 pandemic, and to troubleshoot technical challenges.
35
Total62

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyEquipment malfunction010
Overall StudyWithdrawal by Subject138

Baseline characteristics

CharacteristicExperimental: Expect-YesExperimental: Expect-NoBehavioral TestingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
14 Participants13 Participants35 Participants62 Participants
Age, Continuous34.8 years
STANDARD_DEVIATION 9.6
31.7 years
STANDARD_DEVIATION 9.4
28.5 years
STANDARD_DEVIATION 7.3
30.5 years
STANDARD_DEVIATION 8.6
Annual Household Income
$75,000 or more
2 Participants1 Participants9 Participants12 Participants
Annual Household Income
Less than $10,000
2 Participants1 Participants2 Participants5 Participants
Annual Household Income
Less than $15,000 ($10,000 to less than $15,000)
1 Participants0 Participants2 Participants3 Participants
Annual Household Income
Less than $20,000 ($15,000 to less than $20,000)
1 Participants0 Participants1 Participants2 Participants
Annual Household Income
Less than $25,000 ($20,000 to less than $25,000)
2 Participants3 Participants6 Participants11 Participants
Annual Household Income
Less than $35,000 ($25,000 to less than $35,000)
4 Participants3 Participants10 Participants17 Participants
Annual Household Income
Less than $50,000 ($35,000 to less than $50,000)
2 Participants3 Participants3 Participants8 Participants
Annual Household Income
Less than $75,000 ($50,000 to less than $75,000)
0 Participants2 Participants1 Participants3 Participants
Annual Household Income
Not reported
0 Participants0 Participants1 Participants1 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants1 Participants2 Participants5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
12 Participants12 Participants33 Participants57 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants0 Participants1 Participants
Race (NIH/OMB)
Asian
3 Participants5 Participants7 Participants15 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants4 Participants4 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants2 Participants
Race (NIH/OMB)
White
9 Participants6 Participants24 Participants39 Participants
Region of Enrollment
United States
14 participants13 participants35 participants62 participants
Sex: Female, Male
Female
6 Participants4 Participants23 Participants33 Participants
Sex: Female, Male
Male
8 Participants9 Participants12 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 140 / 130 / 35
other
Total, other adverse events
0 / 140 / 130 / 35
serious
Total, serious adverse events
0 / 140 / 130 / 35

Outcome results

Primary

Brain Activation During Smoking-related and Neutral Cues

Blood-oxygen-level dependent (BOLD) signal measured using functional magnetic resonance imaging (fMRI) was analyzed as participants were presented with smoking-related and neutral cues. Following preprocessing with fMRIPrep (version 20.2.7), the FMRI Expert Analysis Tool (FEAT) from FMRIB's Software Library (FSL; version 6.0.7.4) was used to characterize brain activation differences in response to smoking-related versus neutral cues. Contrast of parameter estimate (COPE) values were calculated for each participant, and these COPE values were then extracted for two a priori regions of interest (ROIs) to compare activation patterns between the groups. Larger COPE values indicate greater differences in brain activation between smoking-related and neutral cues,

Time frame: Approximately Day 7 (Visit 2)

Population: Participants who completed the scan session and who provided usable brain imaging data were included in analyses. Participants in the Behavioral Testing Arm did not complete a scan session and were not assessed for brain activation during smoking-related and neutral cues.

ArmMeasureGroupValue (MEAN)Dispersion
Experimental: Expect-YesBrain Activation During Smoking-related and Neutral CuesVentromedial prefrontal cortex ROI (10-mm sphere centered at MNI x = -1, y = 46, z = -7)5.8 contrast of parameter estimateStandard Error 2.4
Experimental: Expect-YesBrain Activation During Smoking-related and Neutral CuesDorsal anterior cingulate cortex ROI (10-mm sphere centered at MNI x = -2, y = 10, z = 38)1.1 contrast of parameter estimateStandard Error 3.4
Experimental: Expect-NoBrain Activation During Smoking-related and Neutral CuesVentromedial prefrontal cortex ROI (10-mm sphere centered at MNI x = -1, y = 46, z = -7)-1.6 contrast of parameter estimateStandard Error 3.8
Experimental: Expect-NoBrain Activation During Smoking-related and Neutral CuesDorsal anterior cingulate cortex ROI (10-mm sphere centered at MNI x = -2, y = 10, z = 38)-4.2 contrast of parameter estimateStandard Error 2.8
Comparison: The null hypothesis was that there is no difference in the population means of the two groups.p-value: 0.13t-test, 2 sided
Comparison: The null hypothesis was that there is no difference in the population means of the two groups.p-value: 0.25t-test, 2 sided
Primary

Coded Facial Expressions Linked to Affect During Smoking-related and Neutral Cues

Subjective affective responses were measured by using FaceReader software (version 9.1.7) to code the valence (positive or negative) of facial movements associated with emotional expression during the presentation of smoking-related and neutral cues. Possible values for valence range from -1 to 1, with higher values indicating greater positive affect,

Time frame: Approximately Day 7 (Visit 2)

Population: Participants who provided usable facial expression data were included in analyses.

ArmMeasureGroupValue (MEAN)Dispersion
Experimental: Expect-YesCoded Facial Expressions Linked to Affect During Smoking-related and Neutral CuesValence during smoking-related cues-.27 units on a scaleStandard Error 0.09
Experimental: Expect-YesCoded Facial Expressions Linked to Affect During Smoking-related and Neutral CuesValence during neutral cues-.27 units on a scaleStandard Error 0.1
Experimental: Expect-NoCoded Facial Expressions Linked to Affect During Smoking-related and Neutral CuesValence during smoking-related cues-.24 units on a scaleStandard Error 0.09
Experimental: Expect-NoCoded Facial Expressions Linked to Affect During Smoking-related and Neutral CuesValence during neutral cues-.25 units on a scaleStandard Error 0.09
Behavioral TestingCoded Facial Expressions Linked to Affect During Smoking-related and Neutral CuesValence during smoking-related cues-.23 units on a scaleStandard Error 0.08
Behavioral TestingCoded Facial Expressions Linked to Affect During Smoking-related and Neutral CuesValence during neutral cues-.18 units on a scaleStandard Error 0.08
Comparison: The null hypothesis was that there is no difference in the population means of the two groups.p-value: 0.8t-test, 2 sided
Comparison: The null hypothesis was that there is no difference in the population means of the two groups.p-value: 0.87t-test, 2 sided
Secondary

Brain Activation During Positive and Negative Emotion Cues

Blood-oxygen-level dependent (BOLD) signal measured using functional magnetic resonance imaging (fMRI) was analyzed as participants were presented with cues designed to elicit positive and negative emotion. Following preprocessing with fMRIPrep (version 20.2.7), the FMRI Expert Analysis Tool (FEAT) from FMRIB's Software Library (FSL; version 6.0.7.4) was used to characterize brain activation in response to positive and negative emotion cues. Contrast of parameter estimate (COPE) values were calculated for each participant, and these COPE values were then extracted for two a priori regions of interest (ROIs) to compare activation patterns between the groups. Larger COPE values indicate greater differences in brain activation between positive and negative emotion cues.

Time frame: Approximately Day 7 (Visit 2)

Population: Participants who completed the scan session and who provided usable brain imaging data were included in analyses (i.e., those with missing data or unusable data due to quality issue such as excessive head motion were excluded). Participants in the Behavioral Testing Arm did not complete a scan session and were not assessed for brain activation during positive and negative emotion cues.

ArmMeasureGroupValue (MEAN)Dispersion
Experimental: Expect-YesBrain Activation During Positive and Negative Emotion CuesVentromedial prefrontal cortex ROI (10-mm sphere centered at MNI x = -1, y = 46, z = -7)2.4 contrast of parameter estimateStandard Error 5.9
Experimental: Expect-YesBrain Activation During Positive and Negative Emotion CuesDorsal anterior cingulate cortex ROI (10-mm sphere centered at MNI x = -2, y = 10, z = 38)-10.8 contrast of parameter estimateStandard Error 4.5
Experimental: Expect-NoBrain Activation During Positive and Negative Emotion CuesVentromedial prefrontal cortex ROI (10-mm sphere centered at MNI x = -1, y = 46, z = -7)5.5 contrast of parameter estimateStandard Error 2.8
Experimental: Expect-NoBrain Activation During Positive and Negative Emotion CuesDorsal anterior cingulate cortex ROI (10-mm sphere centered at MNI x = -2, y = 10, z = 38)-2.2 contrast of parameter estimateStandard Error 5.2
Secondary

Coded Facial Expressions Linked to Affect During Positive and Negative Emotion Cues

Subjective affective responses were measured by using FaceReader software (version 9.1.7) to code the valence (positive or negative) of facial movements associated with emotional expression during the presentation of cues designed to elicit positive and negative emotion. Possible values for valence range from -1 to 1, with higher values indicating greater positive affect,

Time frame: Approximately Day 7 (Visit 2)

Population: Participants who provided usable facial expression data were included in analyses.

ArmMeasureGroupValue (MEAN)Dispersion
Experimental: Expect-YesCoded Facial Expressions Linked to Affect During Positive and Negative Emotion CuesValence during positive emotion cues-.19 units on a scaleStandard Error 0.1
Experimental: Expect-YesCoded Facial Expressions Linked to Affect During Positive and Negative Emotion CuesValence during negative emotion cues-.24 units on a scaleStandard Error 0.1
Experimental: Expect-NoCoded Facial Expressions Linked to Affect During Positive and Negative Emotion CuesValence during positive emotion cues-.17 units on a scaleStandard Error 0.1
Experimental: Expect-NoCoded Facial Expressions Linked to Affect During Positive and Negative Emotion CuesValence during negative emotion cues-.25 units on a scaleStandard Error 0.09
Behavioral TestingCoded Facial Expressions Linked to Affect During Positive and Negative Emotion CuesValence during positive emotion cues.03 units on a scaleStandard Error 0.05
Behavioral TestingCoded Facial Expressions Linked to Affect During Positive and Negative Emotion CuesValence during negative emotion cues-.12 units on a scaleStandard Error 0.04
Secondary

Nicotine Dependence

Participants' level of nicotine dependence was assessed using the total score on the Fagerström Test for Nicotine Dependence to help characterize the sample. Possible scores on the Fagerström Test for Nicotine Dependence range from 0 to 10, with higher scores indicating greater nicotine dependence.

Time frame: Day 1 (Visit 1)

Population: Only participants with usable data for the specified outcome were included in the analysis (i.e., those with missing data were excluded).

ArmMeasureValue (MEAN)Dispersion
Experimental: Expect-YesNicotine Dependence3.8 units on a scaleStandard Error 0.6
Experimental: Expect-NoNicotine Dependence4.1 units on a scaleStandard Error 0.6
Behavioral TestingNicotine Dependence4.4 units on a scaleStandard Error 0.3
Secondary

Self-reported Affect During Positive and Negative Emotion Cues

Participants rated their current affect during the presentation of cues designed to elicit positive and negative emotion on a scale ranging from 1 (very negative) to 9 (very positive), with higher scores indicating greater positive affect. For each type of cue (positive and negative emotion), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.

Time frame: Approximately Day 7 (Visit 2)

Population: Participants who provided usable ratings data were included in analyses.

ArmMeasureGroupValue (MEAN)Dispersion
Experimental: Expect-YesSelf-reported Affect During Positive and Negative Emotion CuesSelf-reported affect during positive emotion cues7.6 units on a scaleStandard Error 0.2
Experimental: Expect-YesSelf-reported Affect During Positive and Negative Emotion CuesSelf-reported affect during negative emotion cues2.8 units on a scaleStandard Error 0.3
Experimental: Expect-NoSelf-reported Affect During Positive and Negative Emotion CuesSelf-reported affect during positive emotion cues6.7 units on a scaleStandard Error 0.3
Experimental: Expect-NoSelf-reported Affect During Positive and Negative Emotion CuesSelf-reported affect during negative emotion cues2.9 units on a scaleStandard Error 0.3
Behavioral TestingSelf-reported Affect During Positive and Negative Emotion CuesSelf-reported affect during positive emotion cues6.4 units on a scaleStandard Error 0.3
Behavioral TestingSelf-reported Affect During Positive and Negative Emotion CuesSelf-reported affect during negative emotion cues3.7 units on a scaleStandard Error 0.3
Secondary

Self-reported Affect During Smoking-related and Neutral Cues

Participants rated their current affect during the presentation of smoking-related and neutral cues on a scale ranging from 1 (very negative) to 9 (very positive), with higher scores indicating greater positive affect. For each type of cue (smoking-related and neutral), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.

Time frame: Approximately Day 7 (Visit 2)

Population: Participants who provided usable ratings data were included in analyses.

ArmMeasureGroupValue (MEAN)Dispersion
Experimental: Expect-YesSelf-reported Affect During Smoking-related and Neutral CuesSelf-reported affect during smoking-related cues6.1 units on a scaleStandard Error 0.3
Experimental: Expect-YesSelf-reported Affect During Smoking-related and Neutral CuesSelf-reported affect during neutral cues5.9 units on a scaleStandard Error 0.2
Experimental: Expect-NoSelf-reported Affect During Smoking-related and Neutral CuesSelf-reported affect during smoking-related cues5.5 units on a scaleStandard Error 0.3
Experimental: Expect-NoSelf-reported Affect During Smoking-related and Neutral CuesSelf-reported affect during neutral cues5.4 units on a scaleStandard Error 0.3
Behavioral TestingSelf-reported Affect During Smoking-related and Neutral CuesSelf-reported affect during smoking-related cues5.1 units on a scaleStandard Error 0.7
Behavioral TestingSelf-reported Affect During Smoking-related and Neutral CuesSelf-reported affect during neutral cues5.9 units on a scaleStandard Error 0.3
Secondary

Self-reported Urge to Smoke During Positive and Negative Emotion Cues

Participants rated their urge to smoke during the presentation of cues designed to elicit positive and negative emotions on a scale ranging from 1 (not at all) to 9 (extremely), with higher scores indicating a stronger desire to smoke. For each type of cue (positive and negative emotion), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.

Time frame: Approximately Day 7 (Visit 2)

Population: Participants who provided usable ratings data were included in analyses. Participants in the Behavioral Testing Arm were not presented with cues designed to elicit positive and negative emotion (they were only presented with smoking-related and neutral cues) and therefore did not provide data for this secondary outcome.

ArmMeasureGroupValue (MEAN)Dispersion
Experimental: Expect-YesSelf-reported Urge to Smoke During Positive and Negative Emotion CuesSelf-reported urge during positive emotion cues3.0 units on a scaleStandard Error 0.3
Experimental: Expect-YesSelf-reported Urge to Smoke During Positive and Negative Emotion CuesSelf-reported urge during negative emotion cues6.1 units on a scaleStandard Error 0.5
Experimental: Expect-NoSelf-reported Urge to Smoke During Positive and Negative Emotion CuesSelf-reported urge during positive emotion cues4.0 units on a scaleStandard Error 0.6
Experimental: Expect-NoSelf-reported Urge to Smoke During Positive and Negative Emotion CuesSelf-reported urge during negative emotion cues5.8 units on a scaleStandard Error 0.4
Secondary

Self-reported Urge to Smoke During Smoking-related and Neutral Cues

Participants rated their urge to smoke during the presentation of smoking-related and neutral cues on a scale ranging from 1 (not at all) to 9 (extremely), with higher scores indicating a stronger desire to smoke. For each type of cue (smoking-related and neutral), repeated ratings were obtained across multiple trials. To report a single value for each Arm/Group, the ratings were averaged across all trials for each cue type.

Time frame: Approximately Day 7 (Visit 2)

Population: Participants who provided usable ratings data were included in analyses.

ArmMeasureGroupValue (MEAN)Dispersion
Experimental: Expect-YesSelf-reported Urge to Smoke During Smoking-related and Neutral CuesSelf-reported urge during smoking-related cues7.4 units on a scaleStandard Error 0.2
Experimental: Expect-YesSelf-reported Urge to Smoke During Smoking-related and Neutral CuesSelf-reported urge during neutral cues4.9 units on a scaleStandard Error 0.6
Experimental: Expect-NoSelf-reported Urge to Smoke During Smoking-related and Neutral CuesSelf-reported urge during smoking-related cues7.1 units on a scaleStandard Error 0.6
Experimental: Expect-NoSelf-reported Urge to Smoke During Smoking-related and Neutral CuesSelf-reported urge during neutral cues5.0 units on a scaleStandard Error 0.6
Behavioral TestingSelf-reported Urge to Smoke During Smoking-related and Neutral CuesSelf-reported urge during smoking-related cues6.3 units on a scaleStandard Error 0.7
Behavioral TestingSelf-reported Urge to Smoke During Smoking-related and Neutral CuesSelf-reported urge during neutral cues3.7 units on a scaleStandard Error 0.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026